Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

ChemoSen3D

ChemoSen3D uses 3D bioprinting technology to rapidly develop clinical assays for personalized medicine.
2018
2-10
Houston, Texas, United States

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

165.K

Last Funding Amount

165.K

Last Funding Date

24-02-2021

Startup Stage

Seed

Something missing or incorrect on this page? Help us enrich this information